Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170M
-
Number of holders
-
74
-
Total 13F shares, excl. options
-
63.4M
-
Shares change
-
-5.67M
-
Total reported value, excl. options
-
$60M
-
Value change
-
-$4.73M
-
Put/Call ratio
-
1.55
-
Number of buys
-
24
-
Number of sells
-
-48
-
Price
-
$0.95
Significant Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q3 2024
103 filings reported holding MCRB - Seres Therapeutics, Inc. - COMMON STOCK as of Q3 2024.
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) has 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 63.4M shares
of 170M outstanding shares and own 37.2% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (23.1M shares), FMR LLC (22.9M shares), VANGUARD GROUP INC (6.06M shares), BlackRock, Inc. (1.76M shares), GEODE CAPITAL MANAGEMENT, LLC (1.39M shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (1.19M shares), MILLENNIUM MANAGEMENT LLC (1.02M shares), MORGAN STANLEY (802K shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (749K shares), and Schonfeld Strategic Advisors LLC (434K shares).
This table shows the top 74 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.